ArticleMicrobial cell factories2025
Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A comprehensive review of microbial exopolysaccharide for bioremediation of environmental pollutants and industrial waste toxicants using sustainable strategies: bottlenecks and future perspectives.World journal of microbiology & biotechnology · 2026Review
- Water-soluble sulfated exopolysaccharide from Cytobacillus oceanisediminis: Its production, characterization and biological activities.Folia microbiologica · 2026Article
- Insights into biosynthesis, regulation, and functional potentials of exopolysaccharide from Leptolyngbya sp. MKU-05.World journal of microbiology & biotechnology · 2025Article
- Microbial Biofertilizers for Salinity Stress Mitigation in Hydroponic Systems.Current issues in molecular biology · 2025Review
- Revealing the therapeutic potential of bioactive exopolysaccharide (EPSS10) derived from Streptomyces sp. MAE.BMC microbiology · 2025Article
- LaponitePharmaceutics · 2025Article
- Heavy metals toxicity in plants: understanding mechanisms and developing coping strategies for remediation: a review.Bioresources and bioprocessing · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is growing interest in the production and characterization of bacterial exopolysaccharides (EPS) because of their diverse range of applications. This study aimed to examine the production of EPS by Pseudomonas aeruginosa AG01, to characterize the produced EPS and its application as antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral activity. The results indicated that the ideal conditions for achieving the highest production of EPS included an incubation period of 96 h, a pH level of 6, and a temperature of 32 °C in a nutrient broth medium. The most efficient sources of carbon and nitrogen for the formation of EPS were found to be galactose, glucose, yeast extract, and peptone. Several functional groups were confirmed to be present by Fourier transform infrared spectroscopy including amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. In the same respect, EPS has antioxidant activity. Moreover, EPS produced by Pseudomonas aeruginosa AG01 demonstrated antibacterial activity against various Gram-positive, Gram-negative bacteria, and yeast, besides antibiofilm activity about 98.93%, 98.86%, 98.63%, and 97.19% for Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli, respectively as well as anticancer activity against prostate cancer (PC3) and breast cancer (MCF7) cells with IC50 values of 156.41 and 156.41 µg/ml, respectively. Flow cytometry analysis revealed that MCF7 cells treated with EPS at a concentration of 500 µg/ml for 48 h showed a reduction in the percentage of cells in both the G0/G1 and S phases compared to the untreated control MCF7 cells. EPS resulted in apoptosis induction in MCF7 cells using the Annexin V-FITC PI staining method. The findings indicate that EPS demonstrates significant antiviral activity against both the herpes simplex virus (HSV-1) and the hepatitis A virus (HAV). In conclusion, EPS has great potential to be developed as a natural antioxidant or used in medicine and pharmaceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.